Publications by authors named "Xumeng Ji"
Thorac Cancer
August 2024
Article Synopsis
- Immune checkpoint inhibitors (ICIs) have improved survival rates for female patients with extensive-stage small-cell lung cancer (ES-SCLC), but most previous studies focused on male participants.
- This study divided female ES-SCLC patients into two groups: those receiving first-line therapy with or without ICIs, and those undergoing second-line treatments, finding better survival outcomes for those on ICIs.
- Though ICIs correlated with longer progression-free and overall survival, they also resulted in a higher rate of serious adverse events (AEs), emphasizing the need for careful monitoring in these patients.
